Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research.

This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare Summit.